What homocysteine is
Homocysteine is a sulfur-containing amino acid that is not obtained from diet but is produced in the body as an intermediate in methionine metabolism. Methionine (from dietary protein) is converted to S-adenosylmethionine (SAM), the body's primary methyl donor. After donating a methyl group, SAM becomes homocysteine. Homocysteine is then either recycled back to methionine (via B12 and folate-dependent pathways) or converted to cysteine (via the B6-dependent transsulfuration pathway).
When these recycling and clearance pathways are impaired — due to B12 deficiency, folate deficiency, MTHFR variants, or B6 deficiency — homocysteine accumulates in the blood and damages tissues.
Why elevated homocysteine matters
Elevated homocysteine is an independent risk factor for:
- Cardiovascular disease — damages vascular endothelium, promotes LDL oxidation, stimulates smooth muscle proliferation, impairs nitric oxide signalling
- Stroke — strong independent predictor; multiple meta-analyses confirm causal relationship via Mendelian randomisation
- Cognitive decline and dementia — the VITACOG trial showed that B-vitamin supplementation reducing homocysteine significantly slowed brain atrophy; homocysteine impairs myelination and neuronal function
- Kidney disease — high homocysteine is nephrotoxic and also reduced clearance from impaired kidneys creates a feedback loop
What controls homocysteine levels
Three main nutritional regulators determine your homocysteine level:
- Methylcobalamin (B12) — required for methionine synthase enzyme; deficiency is the most common driver of elevated homocysteine in India; methylcobalamin form preferred over cyanocobalamin
- 5-MTHF (active folate) — required for MTHFR enzyme that regenerates the methyl group donated to homocysteine; 5-MTHF (methylfolate) bypasses the MTHFR step; regular folic acid requires functional MTHFR to activate
- Pyridoxal-5-phosphate (P5P / B6) — drives the transsulfuration pathway converting homocysteine to cysteine; the backup clearance route
- TMG (trimethylglycine / betaine) — provides an alternative methyl group directly, allowing betaine-homocysteine methyltransferase (BHMT) to recycle homocysteine independently of B12 and folate; powerful adjunct
India-specific context
India has among the highest rates of elevated homocysteine globally, driven by two compounding factors:
- Vegetarian diet — B12 is found almost exclusively in animal products; India's large vegetarian population is structurally at risk for B12 depletion and elevated homocysteine
- MTHFR variant prevalence — the MTHFR C677T variant is present in 40–50% of the Indian population in heterozygous form and 10–15% in homozygous form; this significantly impairs folate activation and homocysteine clearance
The combination of low B12 intake and high MTHFR variant prevalence makes elevated homocysteine one of the most clinically significant and underdiagnosed metabolic issues in India.
Interpretation table
| Homocysteine (µmol/L) | Category | Associated Risk | Supplement Protocol |
|---|---|---|---|
| <7 µmol/L | Optimal | Minimal cardiovascular/cognitive risk from this marker | Maintain with adequate B12, folate, B6 from diet or supplements |
| 7–10 µmol/L | Low-normal (longevity target range) | Low — within longevity optimal | Ensure dietary B12 adequacy; monitor annually |
| 10–15 µmol/L | Borderline elevated | Moderate increase in CVD and cognitive risk | Methylcobalamin 1000mcg + 5-MTHF 400–800mcg + P5P 50mg + TMG 500mg daily; retest in 3 months |
| 15–30 µmol/L | Elevated | Significant cardiovascular and dementia risk | Same as above at higher doses; TMG 1000–1500mg; confirm B12 and folate levels; check kidney function |
| >30 µmol/L | Hyperhomocysteinaemia | Very high risk; possible genetic enzyme defect | Physician evaluation; rule out CBS enzyme defect; high-dose supplementation protocol |
Supplement protocol to lower homocysteine
Methylcobalamin 1000 mcg/day (sublingual preferred for absorption)
5-MTHF (methylfolate) 400–800 mcg/day — not folic acid for MTHFR variant carriers
P5P (pyridoxal-5-phosphate / B6) 25–50 mg/day
TMG (trimethylglycine) 500–1500 mg/day as adjunct methyl donor
Expect 20–40% homocysteine reduction at 3 months. Retest to confirm. B-complex containing all three in active forms is an efficient way to supplement.
How often to test
Annually as part of a cardiovascular and methylation panel. If supplementing to lower elevated levels: retest at 3 months. Pair with serum B12, active B12 (holotranscobalamin), and folate for a complete methylation picture.
Frequently asked questions
What is a normal homocysteine level in India?
Labs report below 15 µmol/L as normal. The longevity optimal is below 10 µmol/L — ideally 6–9 µmol/L. Above 10 µmol/L warrants supplementation. Above 15 µmol/L is elevated and associated with significant cardiovascular and cognitive risk.
Does B12 lower homocysteine?
Yes — methylcobalamin is one of the three primary nutritional regulators. In B12-deficient individuals (common in Indian vegetarians), supplementing methylcobalamin 1000mcg/day can reduce homocysteine 20–40%. Use methylcobalamin or hydroxocobalamin, not cyanocobalamin.
What is MTHFR and how does it affect homocysteine?
MTHFR is an enzyme that converts folic acid to 5-MTHF (active methylfolate). The C677T variant, present in 40–50% of Indians, reduces enzyme activity 30–65%, impairing homocysteine clearance. If you have this variant, use 5-MTHF instead of regular folic acid.
Can elevated homocysteine cause memory problems?
Yes — independently associated with cognitive decline and Alzheimer's. The VITACOG trial showed B-vitamin treatment significantly slowed brain atrophy. Keeping homocysteine below 10 µmol/L is one of the most evidence-backed strategies for brain longevity.